These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21080738)

  • 1. Drugs in development for tuberculosis.
    Ginsberg AM
    Drugs; 2010 Dec; 70(17):2201-14. PubMed ID: 21080738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Present and future in the use of anti-tubercular drugs].
    Didilescu C; Craiova UM
    Pneumologia; 2011; 60(4):198-201. PubMed ID: 22420168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.
    Sacksteder KA; Protopopova M; Barry CE; Andries K; Nacy CA
    Future Microbiol; 2012 Jul; 7(7):823-37. PubMed ID: 22827305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current development and future prospects in chemotherapy of tuberculosis.
    Nuermberger EL; Spigelman MK; Yew WW
    Respirology; 2010 Jul; 15(5):764-78. PubMed ID: 20546189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis: clinical trials and new drug regimens.
    Kwon YS; Jeong BH; Koh WJ
    Curr Opin Pulm Med; 2014 May; 20(3):280-6. PubMed ID: 24614239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
    Wallis RS; Jakubiec W; Mitton-Fry M; Ladutko L; Campbell S; Paige D; Silvia A; Miller PF
    PLoS One; 2012; 7(1):e30479. PubMed ID: 22279595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New anti-tuberculosis drugs with novel mechanisms of action.
    Rivers EC; Mancera RL
    Curr Med Chem; 2008; 15(19):1956-67. PubMed ID: 18691051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-tuberculosis agents under development and the challenges ahead.
    Kumar D; Negi B; Rawat DS
    Future Med Chem; 2015; 7(15):1981-2003. PubMed ID: 26505682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMC207: the first compound of a new class of potent anti-tuberculosis drugs.
    Matteelli A; Carvalho AC; Dooley KE; Kritski A
    Future Microbiol; 2010 Jun; 5(6):849-58. PubMed ID: 20521931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel drugs against tuberculosis: a clinician's perspective.
    Olaru ID; von Groote-Bidlingmaier F; Heyckendorf J; Yew WW; Lange C; Chang KC
    Eur Respir J; 2015 Apr; 45(4):1119-31. PubMed ID: 25431273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of new drug-regimens against multidrug-resistant tuberculosis.
    Vasava MS; Nair SG; Rathwa SK; Patel DB; Patel HD
    Indian J Tuberc; 2019 Jan; 66(1):12-19. PubMed ID: 30797268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
    Nikonenko BV; Protopopova M; Samala R; Einck L; Nacy CA
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1563-5. PubMed ID: 17242141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antituberculous drugs in development.
    Lalloo UG; Ambaram A
    Curr HIV/AIDS Rep; 2010 Aug; 7(3):143-51. PubMed ID: 20559756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis: the drug development pipeline at a glance.
    Villemagne B; Crauste C; Flipo M; Baulard AR; Déprez B; Willand N
    Eur J Med Chem; 2012 May; 51():1-16. PubMed ID: 22421275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tackling Drug-Resistant Tuberculosis: Current Trends and Approaches.
    Tandon R; Nath M
    Mini Rev Med Chem; 2017; 17(6):549-570. PubMed ID: 27280980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New tuberculosis therapeutics: a growing pipeline.
    Spigelman MK
    J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TB Alliance: overcoming challenges to chart the future course of TB drug development.
    Ginsberg A
    Future Med Chem; 2011 Aug; 3(10):1247-52. PubMed ID: 21859299
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.